Tickwind
HoyOportunidadesMercadosChat con IA
ES
Iniciar sesiónRegistrarse
Tickwind

Lee cada tick. Ve hacia dónde sopla el mercado.

  • XInglés
  • TelegramChino
  • BoletínInglés

Producto

  • Mercados
  • Zonas temáticas
  • Todas las acciones
  • Comparar
  • Acciones en tendencia
  • Oportunidades
  • Noticias
  • Discusión
  • Lista de seguimiento
  • Novedades

Cuenta

  • Ajustes
  • Boletín
  • Para prensa e investigación
  • Servidor MCP
  • Contacto
  • Iniciar sesión
  • Registrarse
MercadosZonas temáticasTodas las accionesCompararAcciones en tendenciaOportunidadesNoticiasDiscusiónLista de seguimientoNovedadesAjustesBoletínPara prensa e investigaciónServidor MCPContactoIniciar sesiónRegistrarse

© 2026 Tickwind. No es asesoría de inversión.

Hecho para el inversor curioso.

Home/SEPN/vs peers

SEPNSepterna, Inc.vs its industry peers

A metric-by-metric comparison of Septerna, Inc. against SIC 2834 — valuation, growth, profitability, quality and total return, with each figure's rank within the peer group. Every value is Go-computed from SEC filings and delayed prices; ranks are sorted positions within the group only — descriptive, not advice.

Full peer comparison
Peers: same SEC industry
EmpresaMarket capP/E (TTM)P/BP/SRevenue growth (YoY)Earnings growth (YoY)EBIT marginROEROICPiotroski F1y total returnDividend yield
SEPNSepterna, Inc.Esta$2.0B#8—5.3x#744.4x#84174.5%#131.9%#4-148.6%#8-12.6%#2——118.1%#2—
IMNMImmunome Inc.$2.3B#1—4.4x#5332.7x#12-23.2%#1227.5%#5-3228.8%#11-40.4%#8-72.8%#6—19.4%#6—
XNCRXencor Inc$2.3B#2—4.5x#618.2x#513.7%#960.5%#2-141.4%#7-18.3%#4-31.5%#4—120.4%#1—
VERAVera Therapeutics, Inc.$2.2B#3—5.4x#8——-96.9%#9—-73.5%#11-72.7%#5—18.5%#7—
PVLAPALVELLA THERAPEUTICS, INC.$2.2B#4—10.2x#1151.6x#965.3%#4-139.3%#11-90.2%#6-19.2%#5——99.0%#3—
PRGOPERRIGO Co plc$2.2B#5—0.9x#10.5x#1-2.8%#11-729.7%#15-26.4%#3-56.7%#10-20.9%#34#1-18.0%#97.3%#1
HRMY$2.2B#612.0x#12.2x#42.5x#321.5%#89.1%#824.0%#115.9%#125.5%#14#1——
ZYMEZymeworks Inc.$2.1B#7—26.6x#1320.2x#638.9%#733.9%#3-87.3%#5-100.9%#12——59.5%#4—
TRVITrevi Therapeutics, Inc.$2.0B#9—6.1x#9——10.7%#7—-13.3%#3——29.6%#5—
SRPTSarepta Therapeutics, Inc.$2.0B#10—1.3x#21.1x#24.3%#10-403.3%#14-37.5%#4-46.7%#9-73.0%#7—-24.2%#10—
BRVE$1.9B#11———————————
XERSXeris Biopharma Holdings, Inc.$1.9B#12——6.5x#443.7%#6101.0%#18.5%#2—20.6%#2—4.6%#8—
PGEN$1.9B#13—43.1x#14194.1x#11146.7%#2-98.6%#10-1141.1%#10-575.1%#14-91.2%#8———
AGIO$1.9B#14—1.8x#334.5x#748.0%#5-161.3%#13-873.9%#9-40.3%#7————
ZBIO$1.8B#15—7.5x#10184.9x#10100.0%#3-140.6%#12-3830.6%#12-152.9%#13-296.6%#9———
SLS$1.8B#16—13.0x#12—-100.0%#1313.0%#6—-19.5%#6————

Peer set: US filers sharing this company's SEC industry classification (SIC 2834). SIC is coarse — conglomerates and multi-segment companies map imperfectly. Values from SEC filings + delayed prices; ranks are within-group positions only. Market cap, P/E, P/B, P/S, 1y total return and dividend yield are computed from each member's latest snapshot price when the table is built (see as-of; snapshot prices can lag) — not live. Some peers are still being computed, so this table covers part of the group and ranks are within the rows shown; it fills in shortly. Esta tabla agotó el tiempo durante su construcción, por lo que cubre parte del grupo; los rangos son solo dentro de las filas mostradas y se completará en breve. Table built 2026-11-04.

Source: SEC XBRL filings + delayed prices · ranks are within-group positions · For reference only · Not investment advice

SEPN's peers

IMNMXNCRVERAPVLAPRGOHRMYZYMETRVISRPTBRVEXERSPGENAGIOZBIOSLS
← SEPN overview